ABBV AbbVie PE ratio, current and historical analysis

As at Apr 21, 2025, the ABBV stock has a PE ratio of 70.9. This is based on the current EPS of $2.4 and the stock price of $170.16 per share. An increase of 12% has been seen in the P/E ratio compared to the average of 63.5 of the last 4 quarters.

ABBV PE ratio history

How has ABBV's PE ratio performed in the past

The mean historical PE ratio of AbbVie over the last ten years is 29.67. The current 70.9 PE ratio is 139% above the historical average. Over the past ten years, ABBV's PE ratio was at its highest in the Dec 2024 quarter at 74.04, with a price of $177.7 and an EPS of $2.4. The Mar 2020 quarter recorded the bottom point at 13.44, with a price of $76.19 and an EPS of $5.67.

Today
72.4
Average
29.67
Median
23.72
Minimum
13.44
Maximum
74.04

AbbVie PE ratio by year

Maximum annual increase: 187.98% in 2014

Maximum annual decrease: -68.09% in 2015

Year PE ratio PE change Price EPS
2024 74.04 30.42% $177.7 $2.4
2023 56.77 133.62% $154.97 $2.73
2022 24.3 16.27% $161.61 $6.65
2021 20.9 -46.75% $135.4 $6.48
2020 39.25 134.89% $107.15 $2.73
2019 16.71 -33.48% $88.54 $5.3
2018 25.12 -14.03% $92.19 $3.67
2017 29.22 70.28% $96.71 $3.31
2016 17.16 -8.77% $62.62 $3.65
2015 18.81 -68.09% $59.24 $3.15
2014 58.95 187.98% $65.44 $1.11
2013 20.47 N/A $52.81 $2.58
2012 N/A N/A N/A $3.35
2011 N/A N/A N/A $2.18
2010 N/A N/A N/A $2.65

AbbVie PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 74.04 7.98% $177.7 $2.4
Sep 2024 68.57 19.94% $197.48 $2.88
Jun 2024 57.17 5.79% $171.52 $3
Mar 2024 54.04 -4.81% $182.1 $3.37
Dec 2023 56.77 39.38% $154.97 $2.73
Sep 2023 40.73 47.52% $149.06 $3.66
Jun 2023 27.61 -26.2% $134.73 $4.88
Mar 2023 37.41 53.95% $159.37 $4.26
Dec 2022 24.3 36.36% $161.61 $6.65
Sep 2022 17.82 -17.5% $134.21 $7.53
Jun 2022 21.6 -6.86% $153.16 $7.09
Mar 2022 23.19 10.96% $162.11 $6.99
Dec 2021 20.9 -19.58% $135.4 $6.48
Sep 2021 25.99 -15.31% $107.87 $4.15
Jun 2021 30.69 -20.88% $112.64 $3.67

ABBV average PE ratio chart

What is the average PE ratio of ABBV for the past years

ABBV's current P/E ratio is above the 3, 5 and 10-year historical averages.

3-year avg
43.64
5-year avg
36.74
10-year avg
29.67
15-year avg
N/A

ABBV PE vs peers

What is ABBV's PE ratio compared to its peers

ABBV's PE ratio is lower than its peer stock GILD, but it is greater than LLY's and AZN's. AbbVie's current PE ratio of 70.9 is above the average of its peers, which is 31.75.

Stock name PE ratio Market cap
BIIB Biogen Inc 10.59 $17.38B
PFE Pfizer Inc 15.85 $127.57B
AZN Astrazeneca plc 29.87 $210.24B
NBIX Neurocrine Biosciences Inc 29.93 $10.15B
AMGN Amgen Inc 36.51 $149.47B
LLY ELI LILLY & Co 70.32 $784.09B
ABBV AbbVie Inc 72.4 $306.75B
GILD Gilead Sciences Inc 277.63 $131.38B
BMY Bristol Myers Squibb Co N/A $94.28B

Frequently asked questions

What is AbbVie's PE ratio?

As of Apr 21, 2025, ABBV stock has a price to earnings ratio of 70.9.

What is the 3-year average PE ratio for AbbVie (ABBV)?

The average PE ratio for ABBV stock over the past 3 years is 43.64.

What is the 5-year average PE ratio for AbbVie (ABBV)?

The average PE ratio for ABBV stock over the past 5 years is 36.74.

What is the highest PE ratio for ABBV?

Over the last ten years, the quarterly PE ratio reached a historic high of 74.04 in the Dec 2024 quarter.

How does the current PE ratio for ABBV compare to its historical average?

ABBV's current price to earnings ratio is 139% above its 10-year historical average.

Why is AbbVie's PE ratio so high?

A company with a higher PE ratio may indicate that the market has higher growth expectations for the company's future earnings or profitability.

How is ABBV's PE ratio calculated (AbbVie PE ratio formula)?

The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Apr 21, 2025), AbbVie's stock price is $170.16. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $2.4. Therefore, AbbVie's P/E ratio for today is 70.9. PE RATIO(70.9) = STOCK PRICE($170.16) / TTM EPS($2.4)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.